DEF 14AThe Ballot
4D Molecular Therapeutics, Inc. files DEF 14A
Filed Apr 28, 2026 · 2mo ago · Accession 0001140361-26-017427
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- FDMT
- CIK
- 1650648
- Form type
- DEF 14A
- Filing date
- Apr 28, 2026
- Report date
- Jun 17, 2026
- Document
- ny20063669x1_def14a.htm
- Size
- 5.1 MB